The White House Office of National Drug Control Policy
(ONDCP) has scheduled a webinar for parents who
are concerned about current overdose deaths and opioid misuse. If you are interested in participating, you
must register for the webinar by June 26 (click on the link in the invitation
below). The webinar will be held on July
1, 2015 at 3pm EST.
Below is the invitation
to the webinar from Michael Botticelli, ONDCP’s director, also informally known as the drug czar.
Mr. Botticelli is the first person in substance-abuse (alcohol) recovery to
hold the position.
The ONDCP advises the President on drug-control issues,
coordinates drug-control activities and related funding across the Federal
government, and produces the annual National Drug Control Strategy, which outlines Administration efforts
to reduce illicit drug use, manufacturing and trafficking, drug-related
crime and violence, and drug-related health consequences.
AN INVITATION
I
would like to cordially invite you to join me for a webinar conversation. This
event is designed to be an opportunity for ONDCP to share their recent efforts
to reduce drug overdose deaths and opioid misuse, and to learn from parents
like you how the Administration can assist with your work to keep our children
safe.
The
meeting will take place virtually on July 1, 2015 at 3:00 pm EST.
Please
register for this event here by June 26. You
will be able to share questions when you register, and I will also respond to
live questions during our webinar. Details on how to access the webinar will
only be sent to parties who register. Questions that are submitted for the
postponed webinar have been received and do not need to be posted again.
I encourage you to share this
invitation with other parents
whose lives have been impacted by a child with a substance use disorder. This
conversation is limited to the parents and family members. I hope you can join
me at this webinar to discuss how we can work together to make America
healthier and safer for all.
Thank
you,
Michael
Botticelli,
Director,
White House Office of National Drug Control Policy
No comments:
Post a Comment